Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Valeri

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Modulation of mismatch repair and genomic stability by miR-155Nicola Valeri, Pierluigi Gasparini, Muller Fabbri, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.
Nature Communications|January 15, 2021
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapyMylène Tajan, Marc Hennequart, Eric C Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric CancerFilippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, et al.
Cancer Discovery|May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.
Gut|September 14, 2016
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancersPietro Carotenuto, Matteo Fassan, Rosantony Pandolfo, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Modulation of mismatch repair and genomic stability by miR-155Nicola Valeri, Pierluigi Gasparini, Muller Fabbri, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.
Nature Communications|January 15, 2021
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapyMylène Tajan, Marc Hennequart, Eric C Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric CancerFilippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, et al.
Cancer Discovery|May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.
Gut|September 14, 2016
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancersPietro Carotenuto, Matteo Fassan, Rosantony Pandolfo, et al.
Pageof 10